NASDAQ: SLDB       Solid Biosciences Inc
Last Price Today's Change   Day's Range   Trading Volume
4.66   +0.33 (7.62%)  4.33 - 4.74  751,200


Avg Volume (4 weeks):1,714,870
4 Weeks Range:2.75 - 11.24
4 Weeks Price Volatility (%):
52 Weeks Range:2.75 - 32.85
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Solid Biosciences Inc is a life science company. It is engaged in manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. Solid Biosciences, lead product candidate the SGT-001, is a gene transfer under development to restore functional dystrophin protein expression in patients' muscles. The company's pipeline products are the SB-001 and solid suit. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices. In the assistive device program, the company focuses on producing a wearable assistive device for patients with DMD.

  Be the first to like this.


4706  3347  638  230 

Top 10 Active Counters
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers